Correction (DOI:10.1016/j.jacc.2009.08.005);ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease)

Journal of the American College of Cardiology

Volumn 54, Issue 14, 2009, Pages 1364-1405

  Redberg, Rita F ^a   Benjamin, Emelia J ^a   Bittner, Vera ^a   Braun, Lynne T ^a   Goff Jr , David C ^a   Havas, Stephen ^a   Labarthe, Darwin R ^a   Limacher, Marian C ^a   Lloyd Jones, Donald M ^a   Mora, Samia ^a   Pearson, Thomas A ^a   Radford, Martha J ^a   Smetana, Gerald W ^a   Spertus, John A ^a   Swegler, Erica W ^a  

^a NONE

Author keywords

ACCF AHA Performance Measures; cardiovascular disease; prevention

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT; VARENICLINE;

ADULT; ATHEROSCLEROSIS; BLEEDING; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG MECHANISM; DYSLIPIDEMIA; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE PERSONNEL; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; LIPID ANALYSIS; LOW DRUG DOSE; MASS SCREENING; MEDICAL CARE; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION; STROKE; TOBACCO DEPENDENCE;

ADULT; BENCHMARKING; CARDIOLOGY; CARDIOVASCULAR DISEASES; HUMANS; QUALITY OF HEALTH CARE;

EID: 70349389455     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.04.009     Document Type: Erratum

References (103)

1. Institute of Medicine of the National Academies Committee on Quality of Health Care in America, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century (2001), National Academies Press, Washington, DC
2. Bonow R.O., Bennett S., Casey Jr. D.E., et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures). J Am Coll Cardiol. 46 (2005) 1144-1178
3. American College of Cardiology, American Heart Association, Physician Consortium for Performance Improvement. Clinical Performance Measures: Chronic Stable Coronary Artery Disease. http://www.ama-assn.org/ama1/pub/upload/mm/370/cadminisetjune06.pdf Accessed July 14, 2008
4. American Medical Association. Physician Consortium for Performance Improvement. Clinical Performance Measures: Hypertension. http://www.ama-assn.org/ama1/pub/upload/mm/370/hypertension-8-05.pdf Accessed July 14, 2008
5. Krumholz H.M., Anderson J.L., Brooks N.H., et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol. 47 (2006) 236-265
6. Thomas R.J., King M., Lui K., et al. AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services. J Am Coll Cardiol. 50 (2007) 1400-1433
7. Estes III N.A., Halperin J.L., Calkins H., et al. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation). J Am Coll Cardiol. 51 (2008) 865-884
8. Spertus J.A., Eagle K.A., Krumholz H.M., et al. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol. 45 (2005) 1147-1156
9. Krumholz H.M., Brindis R.G., Brush J.E., et al. Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Circulation. 113 (2006) 456-462
10. Newman III W.P., Wattigney W., and Berenson G.S. Autopsy studies in United States children and adolescents: relationship of risk factors to atherosclerotic lesions. Ann N Y Acad Sci. 623 (1991) 16-25
11. Strong J.P., Malcom G.T., McMahan C.A., et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 281 (1999) 727-735
12. Stamler J., Stamler R., Neaton J.D., et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA. 282 (1999) 2012-2018
13. Daviglus M.L., Stamler J., Pirzada A., et al. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA. 292 (2004) 1588-1592
14. Lloyd-Jones D.M., Leip E.P., Larson M.G., et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 113 (2006) 791-798
15. Stampfer M.J., Hu F.B., Manson J.E., et al. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 343 (2000) 16-22
16. Daviglus M.L., Liu K., Pirzada A., et al. Favorable cardiovascular risk profile in middle age and health-related quality of life in older age. Arch Intern Med. 163 (2003) 2460-2468
17. Daviglus M.L., Liu K., Greenland P., et al. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs. N Engl J Med. 339 (1998) 1122-1129
18. Kavey R.E., Daniels S.R., Lauer R.M., et al. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 107 (2003) 1562-1566
19. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 117 (2008) e25-e146
20. Hollister Jr. D., Romanello J.M., Smith M.L., et al. Use of physician-specific data and flow sheets to improve compliance with preventive and screening health care measures. Conn Med. 70 (2006) 613-620
21. Dove J.T. The electronic health record: the time is now. Am Heart Hosp J. 3 (2005) 193-200
22. Pearson T.A., Blair S.N., Daniels S.R., et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation. 106 (2002) 388-391
23. Guide to Clinical Preventive Services 2007: Recommendations of the U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality. https://www.oxhp.com/secure/materials/member/adult_preventive.pdf Accessed June 3, 2009
24. De B.G., Ambrosioni E., Borch-Johnsen K., et al. European guidelines on cardiovascular disease and prevention in clinical practice. Atherosclerosis. 171 (2003) 145-155
25. Mosca L., Banka C.L., Benjamin E.J., et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 115 (2007) 1481-1501
26. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart. 91 suppl 5 (2005) v1-v52
27. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 106 (2002) 3143-3421
28. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 42 (2003) 1206-1252
29. Knoops K.T., de Groot L.C., Kromhout D., et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA. 292 (2004) 1433-1439
30. Akesson A., Weismayer C., Newby P.K., et al. Combined effect of low-risk dietary and lifestyle behaviors in primary prevention of myocardial infarction in women. Arch Intern Med. 167 (2007) 2122-2127
31. Appel L.J., Champagne C.M., Harsha D.W., et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 289 (2003) 2083-2093
32. Maruthur N.M., Wang N.Y., and Appel L.J. Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial. Circulation. 119 (2009) 2026-2031
33. Hark L., and Deen Jr. D. Taking a nutrition history: a practical approach for family physicians. Am Fam Physician. 59 (1999) 1521-1522
34. Lloyd-Jones D.M., Nam B.H., D'Agostino Sr. R.B., et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 291 (2004) 2204-2211
35. Murabito J.M., Pencina M.J., Nam B.H., et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA. 294 (2005) 3117-3123
36. Ford E.S., Ajani U.A., Croft J.B., et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 356 (2007) 2388-2398
37. Grandes G., Sanchez A., Sanchez-Pinilla R.O., et al. Effectiveness of physical activity advice and prescription by physicians in routine primary care: a cluster randomized trial. Arch Intern Med. 169 (2009) 694-701
38. McTigue K.M., Harris R., Hemphill B., et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 139 (2003) 933-949
39. Albu J.B., Murphy L., Frager D.H., et al. Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes. 46 (1997) 456-462
40. Wajchenberg B.L., Giannella-Neto D., da Silva M.E., et al. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res. 34 (2002) 616-621
41. Centers for Disease Control and Prevention (CDC). Racial/ethnic disparities in prevalence, treatment, and control of hypertension: United States, 1999-2002. MMWR Morb Mortal Wkly Rep. 54 (2005) 7-9
42. Kearney P.M., Blackwell L., Collins R., et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 371 (2008) 117-125
43. Dhruva S.S., and Redberg R.F. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. Arch Intern Med. 168 (2008) 136-140
44. Walsh J.M., and Pignone M. Drug treatment of hyperlipidemia in women. JAMA. 291 (2004) 2243-2252
45. Hall L.M., Jung R.T., and Leese G.P. Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ. 326 (2003) 251-252
46. Sheridan S.L., and Crespo E. Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms?. A systematic review of the literature. BMC Health Serv Res. 8 (2008) 60
47. Berry J.D., Lloyd-Jones D.M., Garside D.B., et al. Framingham risk score and prediction of coronary heart disease death in young men. Am Heart J. 154 (2007) 80-86
48. Vasan R.S., Sullivan L.M., Wilson P.W., et al. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med. 142 (2005) 393-402
49. Cavanaugh-Hussey M.W., Berry J.D., and Lloyd-Jones D.M. Who exceeds ATP-III risk thresholds?. Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool. Prev Med. 47 (2008) 619-623
50. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation. 97 (1998) 1837-1847
51. D'Agostino Sr. R.B., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 117 (2008) 743-753
52. Conroy R.M., Pyorala K., Fitzgerald A.P., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 24 (2003) 987-1003
53. Ridker P.M., Buring J.E., Rifai N., et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 297 (2007) 611-619
54. Wolf P.A., D'Agostino R.B., Belanger A.J., et al. Probability of stroke: a risk profile from the Framingham Study. Stroke. 22 (1991) 312-318
55. Lumley T., Kronmal R.A., Cushman M., et al. A stroke prediction score in the elderly: validation and Web-based application. J Clin Epidemiol. 55 (2002) 129-136
56. Chambless L.E., Heiss G., Shahar E., et al. Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 160 (2004) 259-269
57. Tanne D., Yaari S., and Goldbourt U. Risk profile and prediction of long-term ischemic stroke mortality: a 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Circulation. 98 (1998) 1365-1371
58. Pencina M.J., D'Agostino Sr. R.B., D'Agostino Jr. R.B., et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 27 (2008) 157-172
59. Pencina M.J., D'Agostino Sr. R.B., D'Agostino Jr. R.B., et al. Comments on 'Integrated discrimination and net reclassification improvements-practical advice.'. Stat Med 27 (2008) 207-212
60. D'Agostino R.B., Wolf P.A., Belanger A.J., et al. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke. 25 (1994) 40-43
61. Wang T.J., Massaro J.M., Levy D., et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA. 290 (2003) 1049-1056
62. Baigent C., Blackwell L., Collins R., et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 373 (2009) 1849-1860
63. Berger J.S., Roncaglioni M.C., Avanzini F., et al. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 295 (2006) 306-313
64. Mora S. Aspirin therapy in women: back to the ABC's. Circ Cardiovasc Qual Outcomes. 2 (2009) 63-64
65. Ogawa H., Nakayama M., Morimoto T., et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA. 300 (2008) 2134-2141
66. Campbell C.L., Smyth S., Montalescot G., et al. Aspirin dose for the prevention of cardiovascular disease: a systematic review. JAMA. 297 (2007) 2018-2024
67. Lee C.D., Folsom A.R., Pankow J.S., et al. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 109 (2004) 855-860
68. Wannamethee S.G., Shaper A.G., and Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart. 90 (2004) 1398-1403
69. Nathan D.M., Cleary P.A., Backlund J.Y., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 353 (2005) 2643-2653
70. Dluhy R.G., and McMahon G.T. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med. 358 (2008) 2630-2633
71. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352 (1998) 837-853
72. McCormack J., and Greenhalgh T. Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study. BMJ. 320 (2000) 1720-1723
73. Holman R.R., Paul S.K., Bethel M.A., et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 359 (2008) 1565-1576
74. National Diabetes Quality Improvement Alliance. Performance Measurement Set for Adult Diabetes. http://www-nehc.med.navy.mil/prevmed/Diabetes/Document%20Folders/DIABETE S/CPG/DQIA.msrs.pdf Accessed December 11, 2007
75. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 317 (1998) 703-713
76. Colhoun H.M., Betteridge D.J., Durrington P.N., et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 364 (2004) 685-696
77. Lichtenstein A.H., Appel L.J., Brands M., et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 114 (2006) 82-96
78. Haskell W.L., Lee I.M., Pate R.R., et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 116 (2007) 1081-1093
79. US Department of Health and Human Services, US Department of Agriculture. Dietary Guidelines for Americans, 2005. 6th edition (2005), US Government Printing Office, Washington, DC HHS Publication No. HHS-ODPHP-2005-01-DGA-A
80. Appel L.J., Moore T.J., Obarzanek E., et al., DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 336 (1997) 1117-1124
81. Your Guide to Lowering Your Blood Pressure with DASH. US Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute. http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf Accessed July 14, 2008
82. US Department of Health and Human Services. Physical Activity and Health: A Report of the Surgeon General (1996), US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Ga. http://www.cdc.gov/nccdphp/sgr/pdf/sgrfull.pdf Available at: http://www.cdc.gov/nccdphp/sgr/pdf/sgrfull.pdf. Accessed July 14, 2008
83. American Medical Association Physician Consortium for Performance Improvement. Clinical Performance Measures: Preventive Care and Screening-Tobacco Use. http://www.ama-assn.org/ama1/pub/upload/mm/370/preventiveset-12-05.pdf Accessed July 14, 2008
84. Conroy M.B., Majchrzak N.E., Silverman C.B., et al. Measuring provider adherence to tobacco treatment guidelines: a comparison of electronic medical record review, patient survey, and provider survey. Nicotine Tob Res. 7 suppl 1 (2005) S35-S43
85. Centers for Disease Control and Prevention (CDC). Tobacco use among adults-United States, 2005. MMWR Morb Mortal Wkly Rep. 55 (2006) 1145-1148
86. Centers for Disease Control and Prevention (CDC). Cigarette smoking-attributable morbidity-United States, 2000. MMWR Morb Mortal Wkly Rep. 52 (2003) 842-844
87. Lancaster T., and Stead L. Physician advice for smoking cessation. Cochrane Database Syst Rev. (2004) CD000165
88. Hughes J., Stead L., and Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. (2004) CD000031
89. Cahill K., Stead L.F., and Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. (2007) CD006103
90. Reeves G.R., Wang T.Y., Reid K.J., et al. Dissociation between hospital performance of the smoking cessation counseling quality metric and cessation outcomes after myocardial infarction. Arch Intern Med. 168 (2008) 2111-2117
91. Ranney L., Melvin C., Lux L., et al. Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Ann Intern Med. 145 (2006) 845-856
92. National Heart, Lung, and Blood Institute, National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf Accessed July 14, 2008
93. US Preventive Services Task Force. Screening for obesity in adults: recommendations and rationale. Ann Intern Med. 139 (2003) 930-932
94. Jakicic J.M., Clark K., Coleman E., et al. American College of Sports Medicine position stand: appropriate intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 33 (2001) 2145-2156
95. Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 290 (2003) 199-206
96. Institute for Clinical Systems Improvement. Health Care Guideline: Preventive Services for Adults. http://www.icsi.org/guidelines_and_more/preventive_services_for_adults_4 .html Accessed July 14, 2008
97. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 21 (2003) 1011-1053
98. US Preventive Services Task Force. Screening for Lipid Disorders in Adults: US Preventive Services Task Force Recommendation Statement. AHRQ Publication No. 08-05114-EF-2. Agency for Healthcare Research and Quality. http://www.ahrq.gov/clinic/uspstf08/lipid/lipidrs.htm Accessed July 14, 2008
99. D'Agostino Sr. R.B., Grundy S., Sullivan L.M., et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 286 (2001) 180-187
100. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: US Preventive Services Task Force recommendation statement. Ann Intern Med. 150 (2009) 396-404
101. US Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med. 136 (2002) 157-160
102. Buse J.B., Ginsberg H.N., Bakris G.L., et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 115 (2007) 114-126
103. National Heart, Lung, and Blood Institute, North American Association for the Study of Obesity. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. http://www.nhlbi.nih.gov/guidelines/obesity/prctgd_c.pdf Accessed July 14, 2008